Annual Retained Earnings
-$1.00 B
-$234.63 M-30.57%
31 December 2023
Summary:
Lyell Immunopharma annual retained earnings is currently -$1.00 billion, with the most recent change of -$234.63 million (-30.57%) on 31 December 2023. During the last 3 years, it has fallen by -$667.97 million (-199.91%). LYEL annual retained earnings is now -672.81% below its all-time high of -$129.67 million, reached on 31 December 2019.LYEL Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.15 B
-$44.58 M-4.02%
30 September 2024
Summary:
Lyell Immunopharma quarterly retained earnings is currently -$1.15 billion, with the most recent change of -$44.58 million (-4.02%) on 30 September 2024. Over the past year, it has dropped by -$203.99 million (-21.49%). LYEL quarterly retained earnings is now -245.11% below its all-time high of -$334.14 million, reached on 01 December 2020.LYEL Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.6% | -21.5% |
| 3 y3 years | -199.9% | -130.3% |
| 5 y5 years | - | - |
LYEL Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -199.9% | at low | -130.3% | at low |
| 5 y | 5 years | -672.8% | at low | -245.1% | at low |
| alltime | all time | -672.8% | at low | -245.1% | at low |
Lyell Immunopharma Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.15 B(+4.0%) |
| June 2024 | - | -$1.11 B(+4.3%) |
| Mar 2024 | - | -$1.06 B(+6.1%) |
| Dec 2023 | -$1.00 B(+30.6%) | -$1.00 B(+5.6%) |
| Sept 2023 | - | -$949.18 M(+5.7%) |
| June 2023 | - | -$898.33 M(+7.7%) |
| Mar 2023 | - | -$834.44 M(+8.7%) |
| Dec 2022 | -$767.48 M | -$767.48 M(+1.1%) |
| Sept 2022 | - | -$759.08 M(+10.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | -$688.83 M(+5.6%) |
| Mar 2022 | - | -$652.51 M(+11.7%) |
| Dec 2021 | -$584.36 M(+74.9%) | -$584.36 M(+16.7%) |
| Sept 2021 | - | -$500.66 M(+10.8%) |
| June 2021 | - | -$451.78 M(+16.1%) |
| Mar 2021 | - | -$389.19 M(+16.5%) |
| Dec 2020 | -$334.14 M(+157.7%) | - |
| Dec 2020 | - | -$334.14 M |
| Dec 2019 | -$129.67 M | - |
FAQ
- What is Lyell Immunopharma annual retained earnings?
- What is the all time high annual retained earnings for Lyell Immunopharma?
- What is Lyell Immunopharma annual retained earnings year-on-year change?
- What is Lyell Immunopharma quarterly retained earnings?
- What is the all time high quarterly retained earnings for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly retained earnings year-on-year change?
What is Lyell Immunopharma annual retained earnings?
The current annual retained earnings of LYEL is -$1.00 B
What is the all time high annual retained earnings for Lyell Immunopharma?
Lyell Immunopharma all-time high annual retained earnings is -$129.67 M
What is Lyell Immunopharma annual retained earnings year-on-year change?
Over the past year, LYEL annual retained earnings has changed by -$234.63 M (-30.57%)
What is Lyell Immunopharma quarterly retained earnings?
The current quarterly retained earnings of LYEL is -$1.15 B
What is the all time high quarterly retained earnings for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly retained earnings is -$334.14 M
What is Lyell Immunopharma quarterly retained earnings year-on-year change?
Over the past year, LYEL quarterly retained earnings has changed by -$203.99 M (-21.49%)